MUC1 has been shown to be overexpressed or aberrantly expressed in both adenocarcinoma and squamous carcinoma NSCLC, as well as in premalignant lesions, including squamous metaplasia and squamous dysplasia [18, 21]. Here, MUC1 is linked to squamous cell carcinoma.